% | $
Quotes you view appear here for quick access.

Abaxis, Inc. Message Board

  • tommccauley31 tommccauley31 Sep 20, 2013 11:34 AM Flag

    Looking better on a technical basis:

    Abaxis dropped like a stone following a
    disappointing earnings report in July.
    IMO the company is oversold, and now
    appears to be close to testing resistance
    mark of $42.48.
    If Abaxis can breakout above the 50 day?
    It is bullish. Abaxis is a growth stock
    with many positive things in the mix.
    I expect good news announcements in
    the human diagnostic sector. Abbott is
    getting traction with Piccolo, and adding
    one big customer like Walgreens, CVS,
    or Walmart could be a game changer.
    ABAX has proven to be a long term hold.
    Buying the dips has been very profitable.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Have you any evidence that "Abbott is gaining traction"?

      • 1 Reply to rainbowmeow2003
      • Rainbow, In a previous post you predicted the
        announcement of a huge opportunity for Abaxis
        coming in the next cc. You implied a deal would
        be with a CRO? Can you elaborate?
        To answer your question.......
        What I know about Abbott is time is on ABAX
        side. The Abbott sale reps are becoming more
        familiar with Piccolo, and their larger sales force
        and worldwide distribution network should make a
        Abbotts relationship with Abaxis began in 2008
        when they dropped Heska, and gave exclusivity of
        the IStat to ABAX. The deal with Abbott getting
        distribution rights to the Piccolo is reciprocity and
        cements the relationship between Abaxis and Abbott.
        What better partner could Abaxis have?
        IMO Abaxis is a potential acquistion candidate.

44.75-2.36(-5.01%)Jun 24 4:00 PMEDT